Amundi
BSX icon

Amundi’s Boston Scientific BSX Stock Holding History

Amundi’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$886M Buy
14,122,913
+1,707,754
+14% +$137M 0.24% 72
2025
Q4 		$1.18B Buy
12,415,159
+433,575
+4% +$42.5M 0.32% 64
2025
Q3 		$1.16B Buy
11,981,584
+1,781,830
+17% +$185M 0.37% 54
2025
Q2 		$1.06B Sell
10,199,754
-2,108,961
-17% -$213M 0.36% 55
2025
Q1 		$1.21B Buy
12,308,715
+311,034
+3% +$31.3M 0.44% 44
2024
Q4 		$1.15B Sell
11,997,681
-560,172
-4% -$49.3M 0.4% 49
2024
Q3 		$1.08B Sell
12,557,853
-2,874,284
-19% -$227M 0.4% 52
2024
Q2 		$1.17B Buy
15,432,137
+4,347,043
+39% +$318M 0.45% 45
2024
Q1 		$747M Sell
11,085,094
-2,610,488
-19% -$168M 0.32% 70
2023
Q4 		$811M Sell
13,695,582
-1,108,328
-7% -$59.2M 0.37% 59
2023
Q3 		$733M Sell
14,803,910
-1,885,154
-11% -$98.9M 0.36% 54
2023
Q2 		$894M Buy
16,689,064
+2,721,748
+19% +$142M 0.45% 38
2023
Q1 		$709M Sell
13,967,316
-329,530
-2% -$15.5M 0.38% 50
2022
Q4 		$655M Sell
14,296,846
-1,110,502
-7% -$48.1M 0.36% 61
2022
Q3 		$636M Buy
15,407,348
+5,164,607
+50% +$207M 0.38% 49
2022
Q2 		$376M Buy
10,242,741
+852,496
+9% +$34.7M 0.3% 85
2022
Q1 		$422M Buy
9,390,245
+1,812,929
+24% +$78.6M 0.29% 88
2021
Q4 		$338M Sell
7,577,316
-206,963
-3% -$8.7M 0.21% 119
2021
Q3 		$338M Buy
7,784,279
+1,498,957
+24% +$66.3M 0.24% 95
2021
Q2 		$269M Buy
+6,285,322
New +$264M 0.19% 131

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amundi's BSX Position: Q1 2026 in Review

Amundi increased its Boston Scientific (BSX) stake by 14% in Q1 2026, buying an estimated $137M and bringing the position to 14,122,913 shares worth $886M. The position accounts for 0.24% of the portfolio, ranked #72.

Amundi first reported a position in BSX in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.21B in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Amundi held 14,122,913 shares of Boston Scientific worth $886M as of Q1 2026.
  • Amundi bought 1,707,754 Boston Scientific shares in Q1 2026, an estimated $137M.
  • Boston Scientific made up 0.24% of Amundi's portfolio in Q1 2026, its #72 holding.
  • Amundi first reported a position in Boston Scientific in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Boston Scientific position peaked at $1.21B in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.